1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSmall Business Innovation Research (SBIR) Program is sponsored by National Cancer Institute (NCI) / National Institutes of Health (NIH). The NCI SBIR program funds researcher-initiated projects that are within NIH's mission to develop cancer technology.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Going Beyond Funding for Next-Generation Cancer Technologies Boosting the Economy and Driving Innovation Between 1998 and 2018, NCI SBIR/STTR awardees fueled $26. 1 billion in economic output, 100,000+ jobs, and breakthrough cancer technologies.
Latest Opportunities with SBIR NCI SBIR/STTR Commercialization Readiness Pilot (CRP) Program The CRP Program helps small businesses with NCI SBIR/STTR projects bridge the gap between late-stage research and commercialization. The application deadline is September 8, 2026.
NCI SBIR/STTR Investor Initiatives Showcase Companies The NCI SBIR/STTR Investor Initiatives Program is specifically designed to connect funded companies with potential investors and strategic partners. Check out the 2026-2027 showcase companies to learn more.
NCI SBIR/STTR Strategic Breakthrough Awards The NCI SBIR/STTR Phase IIB Strategic Breakthrough Award is a first-of-its-kind funding mechanism designed to accelerate late-stage clinical development of technologies addressing pediatric and rare cancers. The application deadline is September 8, 2026. Biomedical researchers at Illumina are developing next-generation tools to analyze genetic variation and function on a massive scale.
Illumina used NCI SBIR funding to develop their next generation sequencing technology.
According to the current listing, eligibility includes: U. S. -based small businesses engaging in scientific research and development that aligns with NCI's mission. Must be at least 51% owned and controlled by U. S. citizens or permanent residents. Confirm the full requirements in the official notice before applying.
The current listing shows varies (e.g., Phase I up to $305,000, Phase II up to $1.25 million). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Innovation Research (SBIR) Program is funded by National Cancer Institute (NCI) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article